Pediatric use of buprenorphine

Drugfree.org has a piece advocating more use of buprenorphine with children. Medication-Assisted Treatment (MAT) for opioid dependence is a science-based and proven-effective option for teens and young adults. It should be administered with age appropriate psychosocial therapy and drug testing. Unfortunately, it has been subject to controversy and stigma. Yet the neuroscience of addiction and … Continue reading Pediatric use of buprenorphine

Addiction Treatment With a Dark Side

The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side

Buprenorphine and emotional reactivity

The following article was shared with me by a reader. Not surprisingly, the emphasized portion below caught my eye. [emphasis mine] Abstract Addictions to illicit drugs are among the nation’s most critical public health and societal problems. The current opioid prescription epidemic and the need for buprenorphine/naloxone (Suboxone®; SUBX) as an opioid maintenance substance, and its … Continue reading Buprenorphine and emotional reactivity

Feds raid Reckitt Benckiser offices; criminal probe underway

Hmmm. All is not well with the manufacturer of Suboxone. Reckitt Benckiser’s offices in Richmond, Va., were raided by a team of IRS and Office of Inspector General (OIG) agents on December  3rd. No one is saying what the feds are investigating, but here is some legal analysis. The search warrant, which company officials say … Continue reading Feds raid Reckitt Benckiser offices; criminal probe underway